Go Pro

Core Scientific (CORZ) 10K Form and Latest SEC Filings 2026

Core Scientific logo
$17.42 -0.61 (-3.38%)
As of 04:00 PM Eastern

Latest Core Scientific SEC Filings & Recent Activity

Core Scientific (NASDAQ:CORZ) has submitted 437+ documents to the U.S. Securities and Exchange Commission (SEC) since 2021. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Core Scientific's financial statements. The most recent filing was a Form 4 submitted on August 26, 2026.

Form 4
Core Scientific, Inc./tx Reports Ownership Change on Aug. 26, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Core Scientific Files Current Report on Aug. 14, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Core Scientific Files Quarterly Report on May. 6, 2026

The 10-Q contains Core Scientific's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Core Scientific SEC Filing History

Browse Core Scientific's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
08/26/2026 3:04 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 3:11 PM
Core Scientific (1839341) Issuer
CRAIN ELIZABETH (1604659) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2026 3:13 PM
Core Scientific (1839341) Issuer
Weiss Eric Stanton (2009491) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2026 3:05 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2026 11:13 AM
Core Scientific (1839341) Subject
Valiant Capital Management, L.P. (1452689) Filed by
Form SCHEDULE 13G/A
08/14/2026 6:02 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2026 3:37 PM
Core Scientific (1839341) Subject
JANE STREET GROUP, LLC (1595888) Filed by
Form SCHEDULE 13G/A
08/12/2026 3:20 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2026 3:40 PM
Citadel Securities GP LLC (1721695) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G
08/04/2026 4:37 PM
Core Scientific (1839341) Subject
Situational Awareness LP (2045724) Filed by
Form SCHEDULE 13D/A
07/31/2026 9:18 AM
Core Scientific (1839341) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
07/22/2026 3:10 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2026 3:16 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2026 3:16 PM
Core Scientific (1839341) Issuer
Sullivan Adam Taylor (1980208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2026 4:41 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2026 3:32 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2026 3:45 PM
Core Scientific (1839341) Subject
DUCHENE TODD M (1248745) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2026 6:17 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 6:18 PM
Core Scientific (1839341) Issuer
Sullivan Adam Taylor (1980208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2026 3:02 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2026 3:14 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2026 3:20 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 3:19 PM
Core Scientific (1839341) Subject
JANE STREET GROUP, LLC (1595888) Filed by
Form SCHEDULE 13G
05/26/2026 3:02 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2026 3:20 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2026 6:46 PM
Core Scientific (1839341) Subject
Valiant Capital Management, L.P. (1452689) Filed by
Form SCHEDULE 13G/A
05/15/2026 3:49 PM
Citadel Securities GP LLC (1721695) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G/A
05/15/2026 11:29 AM
Core Scientific (1839341) Subject
SUSQUEHANNA SECURITIES, LLC (1446580) Filed by
Form SCHEDULE 13G/A
05/13/2026 3:06 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 3:03 PM
Core Scientific (1839341) Issuer
Ray Jorge L. (2123780) Reporting
Form 3
Initial statement of beneficial ownership of securities  
05/06/2026 3:54 PM
Core Scientific (1839341) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2026 3:15 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2026 3:02 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2026 3:06 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2026 6:52 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2026 11:56 AM
Core Scientific (1839341) Subject
VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by
Form SCHEDULE 13G
04/27/2026 4:30 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2026 7:59 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
04/22/2026 3:01 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2026 6:36 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2026 8:50 PM
Core Scientific (1839341) Issuer
Sullivan Adam Taylor (1980208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
Your withdrawal order could cost you in taxes (Ad)

If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answer to a multi-variable problem. Withdrawal sequencing, sequence-of-returns risk, Roth conversion timing, and legacy goals can all shift your real number significantly. Research from Vanguard suggests advisor best practices - covering allocation, rebalancing, tax management, and behavioral coaching - may add roughly 3% in net annual return potential. Morningstar's 2025 data shows the average investor return gap is 1.2% per year due to mistimed buying and selling. Get matched with a fiduciary advisor in your area at no cost and with no obligation to hire.tc pixel

Answer three quick questions to find your advisor match today
04/17/2026 8:50 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2026 7:35 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
04/15/2026 3:02 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2026 3:32 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2026 7:25 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2026 7:26 PM
Core Scientific (1839341) Issuer
Sullivan Adam Taylor (1980208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 3:44 PM
Core Scientific (1839341) Subject
DUCHENE TODD M (1248745) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2026 3:59 PM
Core Scientific (1839341) Filer
Form DEFA14A
03/31/2026 4:01 PM
Core Scientific (1839341) Filer
Form ARS
03/31/2026 3:55 PM
Core Scientific (1839341) Filer
Form DEF 14A
03/27/2026 5:45 PM
Core Scientific (1839341) Issuer
Nygaard James P Jr (1842273) Reporting
Form 4/A
03/26/2026 4:39 PM
Core Scientific (1839341) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/23/2026 7:29 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2026 7:39 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
03/19/2026 3:06 PM
Core Scientific (1839341) Issuer
Nygaard James P Jr (1842273) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2026 4:14 PM
Core Scientific (1839341) Filer
Form 10-K/A
03/12/2026 11:55 AM
Core Scientific (1839341) Subject
Valiant Capital Management, L.P. (1452689) Filed by
Form SCHEDULE 13G
03/10/2026 3:08 PM
Core Scientific (1839341) Issuer
Weiss Eric Stanton (2009491) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 3:13 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2026 8:05 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
03/02/2026 3:44 PM
Core Scientific (1839341) Filer
Form 10-Q/A
03/02/2026 3:18 PM
Core Scientific (1839341) Filer
Form 10-K/A
02/19/2026 8:17 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
02/19/2026 10:56 AM
Core Scientific (1839341) Filer
Form 8-K/A
02/18/2026 4:16 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2026 10:11 AM
BARCLAYS PLC (312069) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G/A
02/09/2026 5:08 PM
Core Scientific (1839341) Subject
Valiant Capital Management, L.P. (1452689) Filed by
Form SCHEDULE 13G/A
02/06/2026 3:11 PM
Core Scientific (1839341) Issuer
Weiss Eric Stanton (2009491) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2026 3:11 PM
Core Scientific (1839341) Issuer
Rozov Yadin (1921268) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2026 3:11 PM
Core Scientific (1839341) Issuer
CRAIN ELIZABETH (1604659) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2026 3:11 PM
Core Scientific (1839341) Issuer
Levy Jordan (1541436) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2026 3:11 PM
Booth Jeffrey David (2009493) Reporting
Core Scientific (1839341) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2026 3:15 PM
Core Scientific (1839341) Issuer
Sullivan Adam Taylor (1980208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2026 8:07 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
01/07/2026 1:59 PM
Core Scientific (1839341) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
01/02/2026 5:26 PM
Core Scientific (1839341) Issuer
Rozov Yadin (1921268) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 7:17 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
12/10/2025 5:12 PM
Citadel Securities GP LLC (1721695) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G
12/01/2025 7:04 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
11/17/2025 5:35 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
11/13/2025 4:42 PM
Core Scientific (1839341) Subject
SUSQUEHANNA SECURITIES, LLC (1446580) Filed by
Form SCHEDULE 13G/A
11/12/2025 3:05 PM
BARCLAYS PLC (312069) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G
11/03/2025 5:42 PM
Core Scientific (1839341) Subject
Form SCHEDULE 13G
11/03/2025 5:42 PM
Core Scientific (1839341) Subject
Valiant Capital Management, L.P. (1452689) Filed by
Valiant Capital Management, L.P. (1452689) Filed by
Form SCHEDULE 13G
10/31/2025 4:16 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
10/31/2025 3:27 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2025 3:18 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2025 9:55 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2025 9:28 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2025 4:00 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form DFAN14A
The retirement stock I'd buy before Nvidia today (Ad)

In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required.tc pixel

Get Marc Chaikin's free presentation on this overlooked AI stock now
10/24/2025 3:14 PM
Core Scientific (1839341) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2025 3:06 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2025 4:20 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
10/22/2025 3:44 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2025 3:44 PM
Core Scientific (1839341) Subject
Form 425
10/21/2025 4:22 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form DFAN14A
10/17/2025 4:00 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form DFAN14A
10/17/2025 5:09 AM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
10/16/2025 4:22 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
(Data available from 1/1/2016 forward)

Core Scientific SEC Filings - Frequently Asked Questions

Core Scientific (CORZ) has submitted 437+ filings to the SEC since 2021. You can browse the complete history or filter by form type using the tools above.

Core Scientific's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Core Scientific's financial statements page.

The most recent filing was a Form 4 submitted on August 26, 2026. This was an insider ownership change filed by 4 - Core Scientific, Inc./tx (0001839341) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NASDAQ:CORZ are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 8/26/2026. New filings are added as they're published.
From Our Partners